Chemoinformaics analysis of (+)-Alpha-Cyperone
| Molecular Weight | 218.34 | nRot | 1 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 13 |
| Exact Molecular Weight | 218.167 | nRing | 2 |
| Solubility: LogS | -3.887 | nHRing | 0 |
| Solubility: LogP | 3.325 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 40.5214 |
| nHD | 0 | BPOL | 22.9386 |
| QED | 0.61 |
| Synth | 4.443 |
| Natural Product Likeliness | 2.474 |
| NR-PPAR-gamma | 0.202 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.2 |
| Pgp-sub | 0.002 |
| HIA | 0.005 |
| CACO-2 | -4.574 |
| MDCK | 0.0000178 |
| BBB | 0.958 |
| PPB | 0.82726 |
| VDSS | 2.355 |
| FU | 0.111737 |
| CYP1A2-inh | 0.062 |
| CYP1A2-sub | 0.865 |
| CYP2c19-inh | 0.079 |
| CYP2c19-sub | 0.918 |
| CYP2c9-inh | 0.074 |
| CYP2c9-sub | 0.233 |
| CYP2d6-inh | 0.047 |
| CYP2d6-sub | 0.836 |
| CYP3a4-inh | 0.474 |
| CYP3a4-sub | 0.562 |
| CL | 6.425 |
| T12 | 0.366 |
| hERG | 0.001 |
| Ames | 0.045 |
| ROA | 0.41 |
| SkinSen | 0.027 |
| Carcinogencity | 0.905 |
| EI | 0.077 |
| Respiratory | 0.969 |
| NR-Aromatase | 0.439 |
| Antiviral | Yes |
| Prediction | 0.870764 |